Key result
Idiopathic cardiomyopathy is linked to ~53% lower LV beta-receptor concentration on PET vs controls.
Why the study?
Positron emission tomography with 11C-CGP-12177 has potential to noninvasively measure beta-adrenergic receptor concentration, but its clinical value in idiopathic cardiomyopathy was not established.
Does PET with 11C-CGP-12177 accurately and safely assess left ventricular beta-adrenergic receptor concentration in patients with idiopathic dilated cardiomyopathy compared to normal controls?
Case-Control (n=18)
Does PET with 11C-CGP-12177 accurately and safely assess left ventricular beta-adrenergic receptor concentration in patients with idiopathic dilated cardiomyopathy compared to normal controls?
PET with 11C-CGP-12177 provides a safe and reliable noninvasive method to quantify the reduction of left ventricular beta-adrenergic receptors in patients with idiopathic dilated cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May enable noninvasive PET monitoring of beta-receptor density in dilated cardiomyopathy; leaves open clinical utility pending prospective validation.
BACKGROUND Positron emission tomography (PET) with 11C-labeled CGP-12177 (CGP) has been shown to have the potential to noninvasively measure beta-adrenergic receptor concentration in dog heart. The present study was undertaken to evaluate the clinical value of this technique. METHODS AND RESULTS Eight normal subjects and 10 patients with heart failure related to an idiopathic cardiomyopathy were studied. Estimation of beta-receptor concentration was based on a graphic method applied on myocardial PET time-concentration curves obtained after an intravenous injection of 11C-CGP followed 30 minutes later by a coinjection of labeled and unlabeled CGP. The clinical tolerance of these injections was good. Left ventricular concentration of beta-receptors was decreased in patients compared with controls (3.12 +/- 0.51 versus 6.60 +/- 1.18 pmol/mL, respectively; p < 0.001). This 53% decrease agrees with previous in vitro data. In eight of the 10 patients, the beta-receptor concentration obtained from PET was compared with the beta-receptor density determined on left ventricular endomyocardial biopsy samples by in vitro binding technique using 3H-CGP-12177. Results obtained with both techniques were correlated (r = 0.79, p = 0.019). Moreover, decreased beta-receptor concentration correlated with the beta-contractile responsiveness to intracoronary dobutamine infusion (r = 0.83, p = 0.003), indicating a direct link between changes in the receptor number and its biological function. CONCLUSIONS PET appears to be a safe and reliable method of assessing in vivo changes in the number of left ventricular beta-adrenergic receptor sites of patients with idiopathic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Merlet et al. (1993) conducted a case-control in Heart failure related to idiopathic dilated cardiomyopathy (n=18). Positron emission tomography with 11C-labeled CGP-12177 vs. Normal subjects was evaluated on Left ventricular concentration of beta-receptors (p=<0.001). PET with 11C-CGP-12177 detected a lower left ventricular beta-receptor concentration in idiopathic cardiomyopathy patients than in normal controls.
Synapse has enriched 10 related papers. Consider them for comparative context: